ClinConnect ClinConnect Logo
Search / Trial NCT06500910

Exercise in Prematurely Born Preadolescents to Mitigate Cardiovascular Risk and Improve Cognitive Impairment

Launched by HENNER HANSSEN · Jul 8, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

The EXCELSIOR trial is a study looking at how physical exercise can help improve heart health and brain function in children who were born prematurely (before 32 weeks of pregnancy). In this trial, children aged 6 to 12 years will be randomly placed into two groups: one group will participate in a fun exercise program designed for kids, while the other group will receive general advice on healthy habits and exercise. This study is important because it aims to understand if exercise can make a positive difference in the lives of children who may face health challenges due to their early birth.

To be part of this study, children must be born prematurely and be between 6 and 12 years old. However, children who have certain conditions, like attention disorders requiring special education, serious eye problems, or significant disabilities that prevent them from exercising, won't be eligible. If you decide to participate, you can expect to engage in enjoyable activities that promote physical fitness, all while helping researchers learn how exercise can benefit kids born prematurely. This could be a great opportunity to support your child's health and contribute to important research!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Boys and girls born prematurely (\<= 32th week of gestation)
  • aged 6 to 12 years
  • informed consent provided
  • Exclusion Criteria:
  • attendance of special education services related to attention disorders
  • colour blindness or any chronic eye disorder
  • being under pharmacological treatment for any mental disorder
  • injuries, significant motor- or other disabilities which prohibit the participation in physical exercise
  • visually provoked epilepsy
  • children for whom no informed consent is provided

About Henner Hanssen

Henner Hanssen is a leading clinical trial sponsor dedicated to advancing innovative healthcare solutions through rigorous research and development. With a commitment to improving patient outcomes, the organization specializes in designing and conducting clinical trials across various therapeutic areas. Henner Hanssen collaborates with healthcare professionals, regulatory bodies, and industry partners to ensure compliance with the highest ethical standards and scientific integrity. Their focus on patient-centric approaches and data-driven methodologies positions them as a trusted partner in the clinical research landscape.

Locations

Basel, Basel Stadt, Switzerland

Patients applied

0 patients applied

Trial Officials

Holger Burchert, PhD

Principal Investigator

University of Basel

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported